Manhattan Bridge Capital (LOAN) Competitors $5.05 -0.06 (-1.17%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$5.09 +0.04 (+0.79%) As of 05/21/2025 04:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LOAN vs. OACC, KVAC, PINE, ENPC, INV, MACI, ILPT, FVR, HLXB, and EARNShould you be buying Manhattan Bridge Capital stock or one of its competitors? The main competitors of Manhattan Bridge Capital include Oaktree Acquisition Corp. III Life Sciences (OACC), Keen Vision Acquisition (KVAC), Alpine Income Property Trust (PINE), Executive Network Partnering (ENPC), Innventure (INV), Melar Acquisition Corp. I (MACI), Industrial Logistics Properties Trust (ILPT), FrontView REIT (FVR), Helix Acquisition Corp. II (HLXB), and Ellington Credit (EARN). These companies are all part of the "trading" industry. Manhattan Bridge Capital vs. Oaktree Acquisition Corp. III Life Sciences Keen Vision Acquisition Alpine Income Property Trust Executive Network Partnering Innventure Melar Acquisition Corp. I Industrial Logistics Properties Trust FrontView REIT Helix Acquisition Corp. II Ellington Credit Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) and Manhattan Bridge Capital (NASDAQ:LOAN) are both small-cap financial services companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, community ranking, valuation, media sentiment, analyst recommendations and risk. Is OACC or LOAN more profitable? Manhattan Bridge Capital has a net margin of 56.93% compared to Oaktree Acquisition Corp. III Life Sciences' net margin of 0.00%. Manhattan Bridge Capital's return on equity of 13.06% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Oaktree Acquisition Corp. III Life SciencesN/A N/A N/A Manhattan Bridge Capital 56.93%13.06%7.75% Does the media refer more to OACC or LOAN? In the previous week, Oaktree Acquisition Corp. III Life Sciences had 2 more articles in the media than Manhattan Bridge Capital. MarketBeat recorded 3 mentions for Oaktree Acquisition Corp. III Life Sciences and 1 mentions for Manhattan Bridge Capital. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.67 beat Manhattan Bridge Capital's score of 0.00 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oaktree Acquisition Corp. III Life Sciences 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Manhattan Bridge Capital 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community believe in OACC or LOAN? Manhattan Bridge Capital received 229 more outperform votes than Oaktree Acquisition Corp. III Life Sciences when rated by MarketBeat users. CompanyUnderperformOutperformOaktree Acquisition Corp. III Life SciencesN/AN/AManhattan Bridge CapitalOutperform Votes22976.85% Underperform Votes6923.15% Do institutionals and insiders believe in OACC or LOAN? 21.8% of Manhattan Bridge Capital shares are held by institutional investors. 24.5% of Manhattan Bridge Capital shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has higher earnings and valuation, OACC or LOAN? Manhattan Bridge Capital has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AManhattan Bridge Capital$7.31M7.90$5.48M$0.4710.74 SummaryManhattan Bridge Capital beats Oaktree Acquisition Corp. III Life Sciences on 7 of the 9 factors compared between the two stocks. Get Manhattan Bridge Capital News Delivered to You Automatically Sign up to receive the latest news and ratings for LOAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LOAN vs. The Competition Export to ExcelMetricManhattan Bridge CapitalReal estate investment trusts IndustryFinance SectorNASDAQ ExchangeMarket Cap$57.77M$6.91B$11.49B$8.39BDividend Yield8.93%6.73%5.45%4.10%P/E Ratio10.3160.3022.4819.71Price / Sales7.908.3427.29117.39Price / Cash11.5917.3217.6234.62Price / Book1.351.652.794.50Net Income$5.48M$177.71M$1.04B$248.18M7 Day Performance-1.94%-2.06%-0.02%0.20%1 Month Performance-2.51%1.66%6.70%12.37%1 Year Performance-5.08%0.72%537.71%7.04% Manhattan Bridge Capital Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LOANManhattan Bridge Capital1.1224 of 5 stars$5.05-1.2%N/A-5.4%$57.77M$7.31M10.316OACCOaktree Acquisition Corp. III Life SciencesN/A$10.41+0.1%N/AN/A$233.44MN/A0.00N/ANews CoveragePositive NewsKVACKeen Vision AcquisitionN/A$11.29-0.3%N/A+7.1%$218.64MN/A0.00N/APINEAlpine Income Property Trust3.4707 of 5 stars$15.29+0.7%$19.31+26.3%-6.1%$218.14M$53.97M109.21N/APositive NewsENPCExecutive Network PartneringN/A$5.18+1.4%N/A-15.0%$217.63MN/A0.001INVInnventureN/A$4.45+3.2%$14.00+214.6%N/A$209.62M$1.22M0.00N/APositive NewsEarnings ReportGap UpMACIMelar Acquisition Corp. IN/A$10.33+0.1%N/AN/A$209.39MN/A0.00N/APositive NewsILPTIndustrial Logistics Properties Trust3.5927 of 5 stars$3.25+3.2%$5.00+53.8%-23.3%$208.35M$441.99M-2.23600News CoveragePositive NewsGap UpFVRFrontView REIT3.5681 of 5 stars$12.02+1.5%$19.40+61.5%N/A$207.75M$59.92M0.00N/APositive NewsDividend AnnouncementHLXBHelix Acquisition Corp. IIN/A$10.98+1.2%N/A+5.6%$207.53MN/A0.00N/APositive NewsEARNEllington Credit1.7371 of 5 stars$5.51+2.5%$5.88+6.7%-24.3%$206.76M$15.88M4.92170Earnings Report Related Companies and Tools Related Companies OACC Alternatives KVAC Alternatives PINE Alternatives ENPC Alternatives INV Alternatives MACI Alternatives ILPT Alternatives FVR Alternatives HLXB Alternatives EARN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LOAN) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredHow I profit during chaos…This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. I...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Manhattan Bridge Capital, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Manhattan Bridge Capital With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LOAN Stock Free LOAN Stock Alerts